Share This Author
Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers.
- J. Démolis, C. Martel, C. Funck-Brentano, A. Sachse, H. Weimann, P. Jaillon
- Medicine, BiologyBritish journal of clinical pharmacology
- 2 October 2003
The results indicate that the combination of tedisamil and atenolol is not associated with excessive bradycardia or excessive QT interval prolongation in healthy subjects.
Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension
A combination product of eprosartan 600’mg and HCTZ 12.5 mg was shown to be an effective and well tolerated treatment and the response rate was higher in the combination group compared with the monotherapy group.
Safety and Tolerability of Eprosartan in Combination with Hydrochlorothiazide
The safety and tolerability of eprosartan in combination with hydrochlorothiazide is well tolerated, both as short- and long-term therapy, with most adverse events occurring early.
Eprosartan in the Primary Prevention of Cardiac Allograft Vascular Disease: A Double-Blind Prospectively Randomized Study using Intravascular Ultrasound
- K. Pethig, B. Hornig, C. Bara, B. Schieffer, A. Haverich, A. Sachse
- MedicineThe Journal of international medical research
- 1 October 2008
The angiotensin blocker eprosartan and the calcium antagonist diltiazem were studied in a 24-month prospective, randomized, double-blind trial involving 53 heart transplant patients to compare their effects on the development of post-transplant cardiac allograft vasculopathy.